Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time.
Gonzalez Lopez Ledesma MM, Sanchez L, Ojeda DS, Oviedo Rouco S, Rossi AH, Varese A, Mazzitelli I, Pascuale CA, Miglietta EA, Rodríguez PE, Pallarés HM, Costa Navarro GS, Caramelo JJ, Rothlauf PW, Liu Z, Bloyet LM, Cornejo Pontelli M, Rasetto NB, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Bianchimano L, Ríos AS, Treffinger Cienfuegos MS, Rodriguez García DR, Longueira Y, Laufer N, Alvarez D, Ceballos A, Ochoa V, Monzani C, Turk G, Salvatori M, Carradori J, Prost K, Rima A, Varela C, Ercole R, Toro RI, Gutierrez S, Zubieta M, Acuña D, Nabaes Jodar MS, Torres C, Mojsiejczuk L, Viegas M, Velazquez P, Testa C, Kreplak N, Yanovsky M, Whelan S, Geffner J, Pifano M, Gamarnik AV. Gonzalez Lopez Ledesma MM, et al. Among authors: laufer n. mBio. 2022 Feb 22;13(1):e0344221. doi: 10.1128/mbio.03442-21. Epub 2022 Jan 25. mBio. 2022. PMID: 35073758 Free PMC article.
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
Rossi AH, Ojeda DS, Varese A, Sanchez L, Gonzalez Lopez Ledesma MM, Mazzitelli I, Alvarez Juliá A, Oviedo Rouco S, Pallarés HM, Costa Navarro GS, Rasetto NB, Garcia CI, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Sosa S, Bianchimano L, Rios AS, Treffinger Cienfuegos MS, Caramelo JJ, Longueira Y, Laufer N, Alvarez DE, Carradori J, Pedrozza D, Rima A, Echegoyen C, Ercole R, Gelpi P, Marchetti S, Zubieta M, Docena G, Kreplak N, Yanovsky M, Geffner J, Pifano M, Gamarnik AV. Rossi AH, et al. Among authors: laufer n. Cell Rep Med. 2021 Aug 17;2(8):100359. doi: 10.1016/j.xcrm.2021.100359. Epub 2021 Jul 9. Cell Rep Med. 2021. PMID: 34308389 Free PMC article.
Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina.
Longueira Y, Polo ML; InViV working group; Biobanco de Enfermedades Infecciosas Colección COVID19 working group; Turk G, Laufer N. Longueira Y, et al. Among authors: laufer n. Heliyon. 2021 Oct;7(10):e08140. doi: 10.1016/j.heliyon.2021.e08140. Epub 2021 Oct 7. Heliyon. 2021. PMID: 34642643 Free PMC article.
SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
Giannone D, Vecchione MB, Czernikier A, Polo ML, Gonzalez Polo V, Cruces L, Ghiglione Y, Balinotti S; BBEI working group; Longueira Y, Turk G, Laufer N, Quiroga MF. Giannone D, et al. Among authors: laufer n. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.026. Epub 2022 May 27. J Infect. 2022. PMID: 35636532 Free PMC article. No abstract available.
402 results